RxDoctor Payments DataLook up a doctor →

David Conway, MD

Internal Medicine · Littleton, CONPI 1164415691

Payments from drug & device makers

$12,171in general payments, 2019–2025

Across 714 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Novo Nordisk$894
  • Pfizer$737
  • AstraZeneca$679
  • Lilly USA, LLC$525
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)131$2,243
Amgen(2 entities)76$1,182
Novo Nordisk56$894
Pfizer50$737
AstraZeneca(2 entities)32$679
Lilly USA, LLC36$525
Novartis25$458
Johnson & Johnson(2 entities)27$443
Antares Pharma, Inc.22$403
Boehringer Ingelheim22$342
Bayer17$325
Eisai Inc.21$280
Astellas Pharma US Inc13$276
Esperion Therapeutics, Inc.15$269
GSK14$262
Exact Sciences10$207
Biohaven Pharmaceutical Holding Company Ltd.6$156
Phathom Pharmaceuticals, Inc.3$156
Merck10$152
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$127
Ironwood Pharmaceuticals, Inc6$121
Amarin Pharma, Inc.6$97
Sanofi-aventis U.S. LLC5$92
Otsuka America Pharmaceutical, Inc.5$92
Edwards Lifesciences3$86
Currax Pharmaceuticals LLC6$85
Kowa Pharmaceuticals America, Inc.6$77
Sumitomo Pharma America, Inc.4$77
Radius Health, Inc.4$75
Bausch Health US, LLC3$70
E.r. Squibb & Sons, L.L.C.4$63
Sunovion Pharmaceuticals Inc.4$60
Nestle Healthcare Nutrition Inc.3$59
Boston Scientific2$55
Biohaven Pharmaceuticals, Inc.3$53
Paratek Pharmaceuticals, Inc.4$53
Hikma Pharmaceuticals USA3$47
IBSA Pharma Inc.3$47
Halozyme Inc3$45
Medtronic3$44
Grifols USA, LLC2$44
Gilead2$39
Insmed, Inc.2$37
Alfasigma USA, Inc.2$34
Teva Pharmaceuticals USA, Inc.2$34
Lucid Diagnostics Inc.2$34
Alkermes, Inc.2$32
BETA Bionics, Inc.1$31
Idorsia Pharmaceuticals US Inc2$29
Inogen, Inc.1$29
Clarus Therapeutics Inc.3$28
Avanir Pharmaceuticals, Inc.2$26
Neuronetics, Inc.1$25
Endo Pharmaceuticals Inc.2$24
GE HealthCare1$20
Inspire Medical Systems, Inc.1$20
Pulmonx Corporation1$19
Lundbeck LLC1$18
Abbott1$18
Nevro Corp.1$17

How this compares

$12,171 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$107,027
Medicare patients
230
Services billed
5,864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Littleton

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →